MedImmune

from Wikipedia, the free encyclopedia

MedImmune, LLC is an American biotechnology company. It was founded in the 1980s and went public in 1990. It is based in Gaithersburg , Maryland . His best known product is the flu vaccine FluMist .

The company was acquired by AstraZeneca in 2007 for more than $ 15 billion.

MedImmune is producing a vaccine in the form of a nasal spray for the American government against the flu, which emerged as a pandemic in 2009 . It was approved in the United States on September 15, 2009 as Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal .

Individual evidence

  1. FluMist nasal flu vaccine spray
  2. Astrazeneca swallows Medimmune. In: Manager-Magazin , April 23, 2007 ( online )
  3. a b MedImmune ( Memento of the original from September 24, 2009 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. @1@ 2Template: Webachiv / IABot / www.medimmune.com
  4. Manufacturer's instructions for use for the vaccine (PDF; 216 kB)

Web links